To improve the management of coronary artery disease and lay the groundwork for future advancements in stent technology, ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The U.S. Coast Guard Cutter Resolute returned to its homeport of St. Petersburg, Fla., on Wednesday, bearing a sizable haul of contraband and five suspected smugglers, according to a U.S. Coast ...

and will compare it to an historical control group of patients that have received drug-eluting stents through Medtronic’s prior clinical studies of its Resolute Onyx implant. Participants in ...

Medtronic has received investigational device ... DCB against drug-eluting stents using historical control data from the Resolute Onyx Clinical Program. For both cohorts, the primary endpoint ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

A dominant winner of the King George VI and Queen Elizabeth Stakes (G1) on his most recent appearance July 27, Goliath brushed away the cobwebs accrued during an 85-day absence with a snug defeat ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...